Reuters logo
BRIEF-Radius Health receives notification of PDUFA extension for abaloparatide-sc
March 10, 2017 / 2:23 PM / 7 months ago

BRIEF-Radius Health receives notification of PDUFA extension for abaloparatide-sc

March 10 (Reuters) - Radius Health Inc:

* Radius Health Receives notification of PDUFA extension for abaloparatide-sc

* Radius Health Inc- in notice received from FDA last evening, prescription drug user fee act date for abaloparatide-sc has been extended to June 30, 2017

* Radius Health Inc- FDA has not requested any additional information from company

* Radius Health Inc - FDA stated that PDUFA goal date has been extended by three months to allow for a full review of submission Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below